Endarterectomy or carotid artery stenting: the quest continues part two - 13/02/15
, Robbert Meerwaldt, M.D., Ph.D. a, Robert H. Geelkerken, M.D., Ph.D. a, Clark J. Zeebregts, M.D., Ph.D. bAbstract |
Background |
Although randomized trials on carotid artery stenting (CAS) could not establish its equivalence to carotid endarterectomy (CEA) in patients with symptomatic carotid disease, CAS is rapidly evolving. Data on long-term outcome after CAS from randomized trials have now become available and ongoing, prospectively held registries frequently publish their results in increasing numbers of patients. We have therefore reviewed the currently available literature and provide an update of our previous article on this topic.
Data sources |
PubMed literature searches were performed to identify relevant studies regarding current status of CEA and stenting for symptomatic carotid stenosis.
Conclusions |
The efficacy of CAS in patients with symptomatic carotid artery stenosis remains unclear because of varying results in randomized trials. Although multiple registries do report promising results after CAS, peri-interventional stroke/death rates still exceed those rates currently found after CEA. Therefore, CEA remains the “gold standard” in treating these patients.
Le texte complet de cet article est disponible en PDF.Keywords : Carotid artery disease, Stent, Carotid endarterectomy
Plan
Vol 209 - N° 2
P. 403-412 - février 2015 Retour au numéro
Article précédent
- The prognostic value of additional malignant lesions detected by magnetic resonance imaging versus mammography
- Sukamal Saha, Mary Freyvogel, Gregory Johnston, Linda Lawrence, Chris Conlin, Randy Hicks, David Strahle, Alpesh Korant, Mohammed Shaik, David Wiese
- Prothrombin complex concentrate in trauma patients
- Kazuhide Matsushima, Elizabeth Benjamin, Demetrios Demetriades
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?